| 000 | 01278 a2200385 4500 | ||
|---|---|---|---|
| 005 | 20250513125842.0 | ||
| 264 | 0 | _c19971023 | |
| 008 | 199710s 0 0 eng d | ||
| 022 | _a0954-6111 | ||
| 024 | 7 |
_a10.1016/s0954-6111(97)90257-2 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHalme, M | |
| 245 | 0 | 0 |
_aPhase II study of weekly gemcitabine in advanced non-small cell lung cancer. _h[electronic resource] |
| 260 |
_bRespiratory medicine _cAug 1997 |
||
| 300 |
_a423-6 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntimetabolites, Antineoplastic _xadverse effects |
| 650 | 0 | 4 |
_aCarcinoma, Non-Small-Cell Lung _xdrug therapy |
| 650 | 0 | 4 |
_aDeoxycytidine _xadverse effects |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLung Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aSurvival Rate |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 | _aGemcitabine |
| 700 | 1 | _aJekunen, A | |
| 700 | 1 | _aTamminen, K | |
| 700 | 1 | _aMattson, K | |
| 773 | 0 |
_tRespiratory medicine _gvol. 91 _gno. 7 _gp. 423-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0954-6111(97)90257-2 _zAvailable from publisher's website |
| 999 |
_c9300263 _d9300263 |
||